Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer. - Fukushiro-Lopes DF; Hegel AD; Rao V; Wyatt D; Baker A; Breuer EK; Osipo C; Zartman JJ; Burnette M; Kaja S; Kouzoukas D; Burris S; et al. (Oncotarget, 2017)